Chemoinformaics analysis of Tetrahydrogeranyl acetone
| Molecular Weight | 212.333 | nRot | 8 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 2 |
| Exact Molecular Weight | 212.178 | nRing | 0 |
| Solubility: LogS | -2.95 | nHRing | 0 |
| Solubility: LogP | 3.132 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.317 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.578 |
| Synth | 2.83 |
| Natural Product Likeliness | 1.193 |
| NR-PPAR-gamma | 0.269 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.361 |
| Pgp-sub | 0.019 |
| HIA | 0.007 |
| CACO-2 | -4.497 |
| MDCK | 0.0000267 |
| BBB | 0.986 |
| PPB | 0.583603 |
| VDSS | 0.711 |
| FU | 0.320965 |
| CYP1A2-inh | 0.316 |
| CYP1A2-sub | 0.541 |
| CYP2c19-inh | 0.379 |
| CYP2c19-sub | 0.784 |
| CYP2c9-inh | 0.689 |
| CYP2c9-sub | 0.958 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.21 |
| CYP3a4-inh | 0.056 |
| CYP3a4-sub | 0.231 |
| CL | 9.363 |
| T12 | 0.841 |
| hERG | 0.015 |
| Ames | 0.018 |
| ROA | 0.022 |
| SkinSen | 0.927 |
| Carcinogencity | 0.037 |
| EI | 0.984 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.769256 |